Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v20-FR Version v18-FR
Language French French
Date Updated 2019-11-18 2019-10-29
Drug Identification Number 02435675 02435675
Brand name APO-VARENICLINE APO-VARENICLINE
Common or Proper name VARENICLINE VARENICLINE
Company Name APOTEX INC APOTEX INC
Ingredients VARENICLINE VARENICLINE VARENICLINE VARENICLINE
Strength(s) 0.5MG 1MG 0.5MG 1MG
Dosage form(s) KIT TABLET KIT TABLET
Route of administration ORAL ORAL
Packaging size 53 BLS 53 BLS
ATC code N07BA N07BA
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-31 2019-01-31
Estimated end date 2019-11-15 2019-11-15
Actual end date 2019-11-15
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited inventory was released; additional inventory will be available by the end of October Limited inventory was released; additional inventory will be available by the end of October
Health Canada comments